Ethos Technologies Inc.
Ethos operates a digital platform for consumers, independent agents and insurance carriers in the United States to explore, compare and purchase life insurance online. It combines distribution, digital underwriting and policy administration, and offers Term Life, Whole Life and Indexed Universal Life Insurance, as well as Wills & Estate Planning and Supplemental Health Insurance. Its Agent OS supports agent onboarding, quoting, applications and policy management, while APIs allow partners such as fintech companies to offer policies through their own platforms. Ethos contracts with insurance carriers, which assume the risk of policies sold through the platform. Ethos earns commissions from carriers when policies are sold and when policyholders renew in subsequent years. It is a licensed agent in 49 states and also serves as a third-party administrator. Its employees are located in San Francisco and Bengaluru, India, and remotely across the United States and select additional countries.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $LIFE in the last 7 days.
Citigroup kept its Buy rating on Ethos Technologies but raised its price target to $61 from $33, suggesting a 64.3% upside from the Nov 4 close of $37.13. Recent analyst targets range from $44 to $55.
Ethos Technologies (LIFE) shares rose 10% after reporting Q3 revenue growth of 151% to $235.2M, exceeding estimates. The company raised its 2026 revenue outlook to $838M-$842M. Adjusted EBITDA increased 87% to $35M, with margins improving. The board approved a $100M stock buyback. Average revenue per policy declined due to more whole life products.
Barclays kept Ethos Technologies at Overweight, raising its price target to $44 from $37, an 18.9% increase. This implies a 3.2% upside from the Nov 2 close of $42.62.
Recent LIFE coverage spans financial news, earnings and insider activity.
In the last 30 days, LIFE insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($1.5M). The most active reporter was Colis Peter George, CEO and Secretary, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Citigroup kept its Buy rating on Ethos Technologies but raised its price target to $61 from $33, suggesting a 64.3% upside from the Nov 4 close of $37.13. Recent analyst targets range from $44 to $55.
Raised guidance plus strong growth metrics likely supports continued upside momentum, but margin and mix risks (lower revenue per policy) may cap follow-through.
Barclays kept Ethos Technologies at Overweight, raising its price target to $44 from $37, an 18.9% increase. This implies a 3.2% upside from the Nov 2 close of $42.62.
Citizens kept Ethos Technologies at Market Outperform, raising its price target to $55 from $40, a 37.5% increase. This implies a 29.0% upside from the Nov 2 close of $42.62, according to the company.
Baird reaffirmed its Outperform rating for Ethos Technologies and increased its price target to $55 from $32, suggesting a 29% upside from the Nov 2 close of $42.62. The new target represents a 71.9% increase.
AlphAI scores every news story that mentions LIFE with an AI model for sentiment and relevance, and aggregates insider trades from Ethos Technologies Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Citigroup kept its Buy rating on Ethos Technologies but raised its price target to $61 from $33, suggesting a 64.3% upside from the Nov 4 close of $37.13. Recent analyst targets range from $44 to $55.
Ethos Technologies (LIFE) shares rose 10% after reporting Q3 revenue growth of 151% to $235.2M, exceeding estimates. The company raised its 2026 revenue outlook to $838M-$842M. Adjusted EBITDA increased 87% to $35M, with margins improving. The board approved a $100M stock buyback. Average revenue per policy declined due to more whole life products.
Barclays kept Ethos Technologies at Overweight, raising its price target to $44 from $37, an 18.9% increase. This implies a 3.2% upside from the Nov 2 close of $42.62.
Citizens kept Ethos Technologies at Market Outperform, raising its price target to $55 from $40, a 37.5% increase. This implies a 29.0% upside from the Nov 2 close of $42.62, according to the company.
Baird reaffirmed its Outperform rating for Ethos Technologies and increased its price target to $55 from $32, suggesting a 29% upside from the Nov 2 close of $42.62. The new target represents a 71.9% increase.
Ethos Technologies Inc.'s average stock price target increased to $43.12 from $37.5, with a range of $33 to $55, implying 1% upside from the Nov. 2 close. Analysts maintain a consensus 'Buy' rating.
Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Third Quarter Fiscal Year 2026 Financial Results • Q3 Revenue grew 151% year-over-year to $235 million • Q3 Direct Channel Revenue grew 112% year-over-year to $119 million • Q3 Third-Party Channel Revenue grew 209% year-over-year to $116 million Austin,
Ethos (LIFE) and Liberty Mutual expanded their partnership, allowing eligible customers to save on auto and home insurance with an Ethos life policy. The collaboration offers instant life insurance without medical exams, combining Liberty Mutual's brand with Ethos' technology. Both companies aim to simplify insurance for families.
Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $38.36 ($37.64–$39.14, $4.54M total) across 3 trades on 2026-10-15 under a Rule 10b5-1 trading plan.
Colis Peter George (CEO and Secretary) sold 120,000 shares of Ethos Technologies Inc. (LIFE) at an average of $38.39 ($37.64–$39.58, $4.61M total) across 7 trades over 2026-10-14 to 2026-10-16 under a Rule 10b5-1 trading plan.
